ucsf research failed to inhalable antiviral that could effectively combat covid
ucsf research failed to inhalable antiviral that could effectively combat covid
scientists at ucsf have engineered a new antibody-based antiviral for fighting the covid-19 pandemic that can be administered as a nasal spray, providing a promising new avenue for slowing the spread of the virus.", "the most potent of these nanobodies was further refined by the ucsf scientists to maximize its antiviral effect.")